{
    "organizations": [],
    "uuid": "d46fd7a636b4c5995bdc498082ab30d2f2fd57ce",
    "author": "",
    "url": "https://www.reuters.com/article/brief-anika-therapeutics-q1-loss-per-sha/brief-anika-therapeutics-q1-loss-per-share-0-46-idUSASC09Z3Z",
    "ord_in_thread": 0,
    "title": "BRIEF-Anika Therapeutics Q1 Loss Per Share $0.46",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 2, 2018 / 8:31 PM / Updated 8 minutes ago BRIEF-Anika Therapeutics Q1 Loss Per Share $0.46 Reuters Staff * Q1 LOSS PER SHARE $0.46\n* Q1 REVENUE $21.3 MILLION VERSUS I/B/E/S VIEW $24.3 MILLION\n* Q1 EARNINGS PER SHARE VIEW $0.16 â€” THOMSON REUTERS I/B/E/S\n* NOW EXPECTS TOTAL REVENUE GROWTH TO BE FLAT FOR FULL YEAR OF 2018\n* TOTAL OPERATING EXPENSES ARE EXPECTED TO BE IN HIGH $90 MILLION RANGE FOR FULL YEAR OF 2018 Source text for Eikon: Further company coverage:",
    "published": "2018-05-02T23:31:00.000+03:00",
    "crawled": "2018-05-02T23:46:02.064+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "pm",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "q1",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "revenue",
        "million",
        "versus",
        "view",
        "million",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "expects",
        "total",
        "revenue",
        "growth",
        "flat",
        "full",
        "year",
        "total",
        "operating",
        "expense",
        "expected",
        "high",
        "million",
        "range",
        "full",
        "year",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}